These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10984249)

  • 1. The question of a link between insulin-like growth factor physiology and neoplasia.
    Pollak M
    Growth Horm IGF Res; 2000 Apr; 10 Suppl B():S21-4. PubMed ID: 10984249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [GH/IGF-1 and cancer: what's new in this association].
    Castro AM; Guerra-Júnior G
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):833-42. PubMed ID: 16444368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone treatment and cancer risk.
    Banerjee I; Clayton PE
    Endocrinol Metab Clin North Am; 2007 Mar; 36(1):247-63. PubMed ID: 17336744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity.
    Gargosky SE; Nanto-Salonen K; Tapanainen P; Rosenfeld RG
    J Endocrinol; 1993 Mar; 136(3):479-89. PubMed ID: 7682593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme.
    Ono T; Kanzaki S; Seino Y; Baylink DJ; Mohan S
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2111-6. PubMed ID: 8964836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis and the growth hormone-insulin-like growth factor axis.
    Geusens PP; Boonen S
    Horm Res; 2002; 58 Suppl 3():49-55. PubMed ID: 12435898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers.
    de Boer H; Blok GJ; Popp-Snijders C; Stuurman L; Baxter RC; van der Veen E
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1371-7. PubMed ID: 8636336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the GH-IGF axis play a role in cancer pathogenesis?
    Cohen P; Clemmons DR; Rosenfeld RG
    Growth Horm IGF Res; 2000 Dec; 10(6):297-305. PubMed ID: 11161960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
    Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings of the 1st International Workshop on Growth Hormone, Insulin-like Growth Factors and Neoplasia. Boston, Massachusetts, USA. October 1999.
    Growth Horm IGF Res; 2000 Apr; 10 Suppl A():S1-53. PubMed ID: 10984269
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of human growth hormone (GH) administration in GH-deficient adults: a 20-day metabolic ward study.
    Valk NK; vd Lely AJ; de Herder WW; Lindemans J; Lamberts SW
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1070-6. PubMed ID: 7525625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone and the insulin-like growth factor system in myogenesis.
    Florini JR; Ewton DZ; Coolican SA
    Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients.
    Jørgensen JO; Blum WF; Horn N; Møller N; Møller J; Ranke MB; Christiansen JS
    Acta Endocrinol (Copenh); 1993 Jun; 128(6):513-20. PubMed ID: 7687807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Hormone's Links to Cancer.
    Boguszewski CL; Boguszewski MCDS
    Endocr Rev; 2019 Apr; 40(2):558-574. PubMed ID: 30500870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?
    Holly JM; Gunnell DJ; Davey Smith G
    J Endocrinol; 1999 Sep; 162(3):321-30. PubMed ID: 10467223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
    Janssen YJ; Helmerhorst F; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 2000 Jan; 85(1):464-7. PubMed ID: 10634425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment.
    Miell JP; Buchanan CR; Norman MR; Maheshwari HG; Blum WF
    J Endocrinol; 1994 Sep; 142(3):547-54. PubMed ID: 7525826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of serum measurements of insulin-like growth factors and somatomedin binding proteins.
    Ranke MB; Blum WF; Bierich JR
    Acta Paediatr Scand Suppl; 1988; 347():114-26. PubMed ID: 2473597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatomedin C in pediatric pathophysiology.
    Cacciari E; Cicognani A
    Pediatrician; 1987; 14(3):146-53. PubMed ID: 3453495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices.
    Jørgensen JO; Møller N; Lauritzen T; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1616-23. PubMed ID: 2189886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.